HBK Capital Management logo

HBK Capital Management

North America, Texas, United States, Dallas

Description

HBK Capital Management is an alternative investment firm currently managing approximately $9.5 billion in assets.

Investor Profile

HBK Capital Management has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series Unknown rounds (top funding stages).
  • Majority of deals are located in United Kingdom.
  • Strong thematic focus on Biotechnology, Health Care, Medical.

Stage Focus

  • Series Unknown (100%)

Country Focus

  • United Kingdom (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Oncology
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does HBK Capital Management frequently co-invest with?

Iroquois Capital
North America, Tennessee, United States, Nashville
Co-Investments: 1
AW
North America, New York, United States, New York
Co-Investments: 1
MB
North America, New York, United States, New York
Co-Investments: 1
Clarion Capital Partners
North America, New York, United States, New York
Co-Investments: 1
Heights Capital Management
North America, California, United States, San Francisco
Co-Investments: 1
FM
North America, California, United States, San Francisco
Co-Investments: 1
LG
North America, New York, United States, New York
Co-Investments: 1
AI
North America, New York, United States, Greenport
Co-Investments: 1
Highbridge Capital Management
North America, New York, United States, New York
Co-Investments: 1
Bank of America Securities
North America, New York, United States, New York
Co-Investments: 1

What are some of recent deals done by HBK Capital Management?

EUSA Pharma

Hemel Hempstead, Hertford, United Kingdom

EUSA Pharma is a pharmaceutical company developing and licensing late-stage oncology, pain control, and critical care products.

BiotechnologyHealth CareMedicalOncologyPharmaceutical
Series UnknownNov 7, 2006
Amount Raised: $18,600,000

Find More Investors Like HBK Capital Management

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

HBK Capital Management | Pipeseed